Invictus MD Strategies Corp (OTCMKTS: IVITF) has been moving up steadily in recent days ever since the Company completed the acquisition of Leaf Wise, an operator of medical clinics in Alberta. Invictus MD is a volatile runner with a history of big moves.
Invictus operates in the booming cannabis space; according to data published by Forbes, citing Brightfield Group, the global cannabis market is estimated to cross the USD 30 Billion mark by 2021. By end of 2017, the global cannabis market value was estimated at USD 7.7 Billion, in which the U.S. held about 90% of total sales. By 2021, the U.S. is expected to account for only 57% of global cannabis sales. Meanwhile, the global market will continue to mature and is projected to grow at a CAGR of 60%
Invictus MD Strategies Corp (TSXV: GENE) (OTCQX: IVITF) (FRA: 8IS1) is a global cannabis company offering a selection of products under a wide range of lifestyle brands. The Company’s integrated sales approach is defined by five pillars of distribution including medical, adult-use, international, Licensed Producer to Licensed Producer and retail stores. The Company boast includes KISS music legend and business mogul Gene Simmons as Chief Evangelist Officer.
Invictus operates two cannabis production facilities fully licensed under ACMPR in Canada and a third awaiting approval, featuring 100,000 square feet of available grow space today with 200,000 expected by January 2019 and 1 million by end of 2020. Invictus offers a diversified product portfolio with over 69 Health Canada approved strains that will be sold under four lifestyle-inspired cannabis brands for recreational users: Dukes, Zooey, Sterling & Hunt, and Sinister. Invictus employs a multifaceted distribution strategy including medical, recreational, international and retail.
Invictus product portfolio includes 69 Health Canada approved strains that will be sold under four lifestyle-inspired cannabis brands for recreational users: Dukes, Zooey, Sterling & Hunt, and Sinister. Each brand has been crafted for a specific target audience and his or her lifestyle.
To Find out the inside Scoop on Invictus Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
Invictus has completed several financing this year including a $25.5 million debt financing arrangement with ATB Financial secured in August to accelerate the construction of its Phase 3 and Phase 4 cannabis cultivation facilities at Acreage Pharms Ltd as well as a C$23 million bought deal financing led by PI Financial Corp. and GMP Securities L.P. as co-lead underwriters, Canaccord Genuity Corp. and Echelon Wealth Partners Inc.
On November 2 Invictus completed the Leaf Wise acquisition after being approved by the Board and TSXV on October 31, 2018. Leaf Wise employs a patient-first business model that features on-site physicians, educational guides and registration support in just four easy steps. With approximately 3,400 patients registered under Access to Cannabis for Medical Purposes Regulations (“ACMPR”), Leaf Wise will serve as a direct channel to Invictus owned Licensed Producers (“LPs”), fully licensed under ACMPR. Invictus paid $625,000 in its stock.
Invictus CEO Dan Kriznic said “Over the past few months, we have experienced substantial growth in our medical distribution channels as more physicians and patients look to cannabis for treatment. As the industry evolves, we will continue to support research that helps to advance patient care and provide a forum to facilitate and monitor ongoing treatment.”
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $107 million market valuation Invictus is fully funded moving forward having previously completed several financing’s this year. The Company has virtually no debt and fast growing sales reporting $460,985 in revenues for the three months ended July 31, 2018. Invictus is on exciting cannabis play well positioned to cash in on the Canadian cannabis craze; the Company operates two cannabis production facilities fully licensed under ACMPR in Canada and a third awaiting approval, featuring 100,000 square feet of available grow space today with 200,000 expected by January 2019 and 1 million by end of 2020. We will be updating on Invictus when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Invictus.
Sign Up now for our 100% FREE Penny Stock Newsletter
Disclosure: we hold no position in Invictus either long or short and we have not been compensated for this article.